Borosilicate Glass Syringe Cone Coating Adhesion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional cone coatings for borosilicate glass syringes face challenges with adhesion, thermal expansion mismatch, chemical resistance, and lead content limitations, leading to issues like cracking, flaking, and inadequate sealing, which are exacerbated by stricter regulatory requirements for pharmaceutical packaging.
Innovation Solution
A cone coating for borosilicate glass syringes comprising a low-melting glass matrix with a powdered roughness additive, baked below 700°C, achieving a defined surface roughness and thermal expansion matching the glass substrate, while being free from toxic elements like lead, ensuring secure adhesion and tightness without compromising chemical resistance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If lead-containing glass frit is used to lower baking temperature and improve adhesion, then the coating adheres well to borosilicate glass, but the coating becomes toxic and fails regulatory requirements
Solution Approach 1:
The patent changes the chemical composition parameters of the glass frit, specifically replacing lead oxide with alternative oxides like bismuth oxide, zinc oxide, and boron oxide. This compositional parameter change allows the coating to be baked at lower temperatures (below 700°C) without lead, maintaining adhesion while eliminating toxicity to meet regulatory requirements for pharmaceutical packaging.
Solution Approach 2:
The patent uses composite glass frit formulations combining multiple oxide components (bismuth oxide, zinc oxide, boron oxide, silica) to achieve the desired properties. This composite approach allows the coating to exhibit both low melting temperature for good adhesion and lead-free composition for safety, resolving the contradiction between performance and toxicity.
2Object-affected harmful factors
If lead-free glass frit is used to eliminate toxicity, then the coating becomes safe for pharmaceutical use, but the thermal expansion mismatch causes cracking and flaking
Solution Approach 1:
The patent carefully adjusts the chemical composition parameters of the lead-free glass frit to match the thermal expansion coefficient of borosilicate glass. By optimizing the ratios of bismuth oxide, zinc oxide, boron oxide, and silica, the coating's thermal expansion is tuned to be compatible with the substrate, preventing stress-induced cracking and flaking while maintaining lead-free safety.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides a borosilicate glass syringe with enhanced adhesion and sealing capabilities, meeting regulatory standards for pharmaceutical packaging by maintaining chemical resistance and preventing cracking or flaking, while ensuring the coating is environmentally friendly and safe for medical applications.
Implementation Method 1
The glass frit melts and flows during baking
Implementation Method 2
ensure the adhesion of the baked layer to the glass substrate through diffusion processes
Implementation Method 3
liquid organic components that evaporate or decompose during baking
Implementation Method 4
liquid organic components that evaporate or decompose during baking
Data Source
Figure 1
AI summary
The syringe (1) has a cylinder (2) for accommodating liquid medicament, and a cone (3) comprising borosilicate glass having thermal expansion in the range of about 20 to 300 degrees centigrade of less than 6x 10 ->6/Kelvin. The cone encloses an outlet channel (4) and has an outside surface with a coating (5) exhibiting an increased roughness compared to the outside surface. The coating comprises a glass matrix with structure-forming particles embedded in the matrix, where the glass matrix is free of lead, cadmium, mercury and chromium VI. The coating has roughness of about 0.3 and 2 micrometer.